Leave no memory behind.
The beginning of brain health for all, VOINOSIS
Leave no memory behind.
The beginning of brain health for all
VOINOSIS
Held at ICASSP 2023
The MADRess Challenge No.1
Winner of the Multilingual Alzheimer’s Detection Category
2023 Global Startup World Cup
Joint 2nd Place Worldwide
Joint 2nd Place at the 2023 Global Startup World Cup
Why VOINOSIS
VOINOSIS’s validated voice AI technology analyzes voice signals to enable reliable detection,
interpretation,
and monitoring of health-related changes in real clinical and personal care environments.
Proprietary acoustic biomarkers
Multilayer signal decoding
Mutimodal AI screening (Voice + gaze)
Continous ambient monitoring
Scalable agnostic engine
Acoustic Intelligence
Most speech AI starts with transcription. Voinosis starts with the signal itself—capturing subtle acoustic biomarkers that text leaves behind.
View TechnologyProprietary acoustic biomarkers
Most speech AI starts with transcription. Voinosis starts with the signal itself—capturing subtle acoustic biomarkers that text leaves behind.
Multilayer signal decoding
Speech is not one flat signal. We decode it layer by layer—from phonemes to full utterances—to extract the right biomarker at the right level.
Mutimodal AI screening (Voice + gaze)
Voice alone tells a lot. Together with gaze, it tells more. Our multimodal approach delivers more robust and reliable early screening.
Continous ambient monitoring
Built for clinics. Designed for the real world. Voinosis connects assessment, monitoring, and early intervention in one scalable workflow.
Scalable agnostic engine
One core engine. Multiple conditions. Global scale. Our disease-agnostic, language-agnostic architecture is built to expand across neurological and auditory disorders.
Clinical & Research Institutions
VOINOSIS collaborates with leading hospitals and
research institutions to validate and advance its clinical AI technology.
